These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8249381)

  • 41. [Aztreonam in severe gram-negative infections in hospitalized patients. Clinical experience in Spain. Preliminary data].
    García-Rodríguez JA; Rabinad E
    Med Clin (Barc); 1987 Apr; 88(13):538-43. PubMed ID: 3586736
    [No Abstract]   [Full Text] [Related]  

  • 42. A comparative study of cefoxitin, cefotaxime, moxalactam and aztreonam kinetics in saliva.
    Petrikkos G; Androulakis M; Goumas P; Giamarellou H
    Chemioterapia; 1987 Oct; 6(5):355-8. PubMed ID: 3427696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aztreonam activity, pharmacology, and clinical uses.
    Neu HC
    Am J Med; 1990 Mar; 88(3C):2S-6S; discussion 38S-42S. PubMed ID: 2180293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Susceptibility of antibiotic-resistant Gram-negative bacteria to biocides: a perspective from the study of catheter biofilms.
    Stickler DJ
    J Appl Microbiol; 2002; 92 Suppl():163S-70S. PubMed ID: 12000625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aztreonam--an overview.
    Hopefl AW
    Drug Intell Clin Pharm; 1985 Mar; 19(3):171-5. PubMed ID: 3884302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gram-negative aerobic bacterial infections: a focus on directed therapy, with special reference to aztreonam.
    Rev Infect Dis; 1985; 7 Suppl 4():S537-843. PubMed ID: 4081472
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of aztreonam on the fecal aerobic flora in children].
    Borderon JC; Rastegar A; Ramponi N; Gold F; Laugier J
    Pathol Biol (Paris); 1987 May; 35(5):665-8. PubMed ID: 3112714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Aztreonam in the treatment of nosocomial urinary infections].
    Nardini A; Taddei P; Rossi F
    G Ital Chemioter; 1986; 33(2-3):139-42. PubMed ID: 3678719
    [No Abstract]   [Full Text] [Related]  

  • 49. [Imipenem resistance in Gram-negative rods and its consumption between 1999 and 2005].
    Gospodarek E; Gierlotka K; Deptuła A; Michalska A
    Med Dosw Mikrobiol; 2007; 59(3):231-40. PubMed ID: 18078118
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gram-negative bacillary pneumonia in the nosocomial setting. Role of aztreonam therapy.
    Cook JL
    Am J Med; 1990 Mar; 88(3C):34S-37S; discussion 38S-42S. PubMed ID: 2316557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fosfomycin: use beyond urinary tract and gastrointestinal infections.
    Falagas ME; Giannopoulou KP; Kokolakis GN; Rafailidis PI
    Clin Infect Dis; 2008 Apr; 46(7):1069-77. PubMed ID: 18444827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Characteristics of war wound infection].
    Kucisec-Tepes N; Bejuk D; Kosuta D
    Acta Med Croatica; 2006 Sep; 60(4):353-63. PubMed ID: 17048790
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aerobic bacteria isolated from blood cultures of patients and their antibiotic susceptibilities in Harare, Zimbabwe.
    Obi CL; Mazarura E
    Cent Afr J Med; 1996 Dec; 42(12):332-6. PubMed ID: 9164012
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aztreonam in the prevention and treatment of infection in neutropenic cancer patients.
    Rolston KV; Bodey GP; Elting L
    Am J Med; 1990 Mar; 88(3C):24S-29S; discussion 38S-42S. PubMed ID: 2180294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections.
    Suárez CJ; Lolans K; Villegas MV; Quinn JP
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):915-22. PubMed ID: 16307504
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Febrile neutropenia in cancer patients in a tertiary care medical center in Lebanon: microbial spectrum and outcome.
    Hamzeh F; Kanj SS; Uwaydah M
    J Med Liban; 2000; 48(3):136-42. PubMed ID: 11268566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tigecycline: a novel glycylcycline antibiotic.
    Zhanel GG; Karlowsky JA; Rubinstein E; Hoban DJ
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):9-25. PubMed ID: 16441206
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Aztreonam in infections caused by gram-negative aerobic bacilli].
    Rodríguez French A; Kenion G; Rodríguez C
    Rev Med Panama; 1988 Jan; 13(1):4-8. PubMed ID: 3347772
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of aztreonam against other antibiotics used in urinary tract infections.
    Khan MT; Shah SH
    J Ayub Med Coll Abbottabad; 2001; 13(4):22-4. PubMed ID: 11873424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.
    Michalopoulos AS; Tsiodras S; Rellos K; Mentzelopoulos S; Falagas ME
    Clin Microbiol Infect; 2005 Feb; 11(2):115-21. PubMed ID: 15679485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.